Scarica l'app Stockscreener
36.39
2.10%
-0.78
Dopo l'orario di chiusura:
36.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$37.17
Aprire:
$37.29
Volume 24 ore:
193.36K
Relative Volume:
0.63
Capitalizzazione di mercato:
$741.18M
Reddito:
$982.01M
Utile/perdita netta:
$14.80M
Rapporto P/E:
98.35
EPS:
0.37
Flusso di cassa netto:
$37.02M
1 W Prestazione:
-5.04%
1M Prestazione:
-11.63%
6M Prestazione:
+105.36%
1 anno Prestazione:
+58.98%
Intervallo 1D:
$35.81
$37.40
Intervallo di 1 settimana:
$35.81
$38.77
Portata 52W:
$16.16
$41.57
Phibro Animal Health Corp Stock (PAHC) Company Profile
Nome
Phibro Animal Health Corp
Settore
Telefono
201-329-7300
Indirizzo
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Confronta PAHC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
36.39 | 1.51B | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Iniziato | JP Morgan | Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Underperform |
| 2022-12-21 | Iniziato | ROTH Capital | Buy |
| 2022-07-25 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2021-07-07 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Downgrade | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Reiterato | BofA/Merrill | Underperform |
| 2019-06-11 | Iniziato | Barclays | Underweight |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-05-09 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Ripresa | BofA/Merrill | Underperform |
| 2017-06-02 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Iniziato | Piper Jaffray | Overweight |
| 2016-11-11 | Downgrade | Macquarie | Neutral → Underperform |
| 2016-11-10 | Downgrade | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Reiterato | Guggenheim | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2016-01-15 | Downgrade | Barclays | Overweight → Underweight |
| 2015-09-30 | Iniziato | Gabelli & Co | Buy |
| 2015-04-24 | Reiterato | Barclays | Overweight |
| 2015-04-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Iniziato | Barclays | Overweight |
Mostra tutto
Phibro Animal Health Corp Borsa (PAHC) Ultime notizie
Can Phibro Animal Health Corporation (PB8) stock double in coming yearsJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
State of Alaska Department of Revenue Buys 859 Shares of Phibro Animal Health Corporation $PAHC - Defense World
PAHC Secures Licensing Agreement for Canine Periodontal Health - GuruFocus
Phibro Animal Health licenses novel canine periodontal therapy - Investing.com
Phibro Animal Health announces licensing pact with Lighthouse Pharmaceuticals - TipRanks
Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs - FinancialContent
Phibro Animal Health Corporation stock trend outlook and recovery pathMarket Trend Report & Capital Protection Trade Alerts - newser.com
Phibro Animal Health Corporation : New Animal Growth Phase - MarketScreener
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term - Yahoo Finance
Public Employees Retirement System of Ohio Sells 4,480 Shares of Phibro Animal Health Corporation $PAHC - Defense World
Published on: 2025-10-06 00:49:27 - newser.com
Can Phibro Animal Health Corporation (PB8) stock expand revenue streams2025 Market WrapUp & Daily Price Action Insights - newser.com
What’s next for Phibro Animal Health Corporation stock priceJuly 2025 Trends & Community Verified Trade Signals - newser.com
Is Phibro Animal Health Corporation a good long term investmentMarket Entry Points & Affordable Investment Strategies - earlytimes.in
Will Phibro Animal Health Corporation stock deliver strong dividend growthAnalyst Upgrade & Smart Investment Allocation Insights - newser.com
Reversal indicators forming on Phibro Animal Health Corporation stockMarket Trend Report & Reliable Intraday Trade Plans - newser.com
Phibro Animal Health (NASDAQ:PAHC) Upgraded at Zacks Research - Defense World
Phibro Animal Health Corporation (PAHC) Soars 39% in Q4, Stock Up 80% YTD on Zoetis Acquisition Boost - Insider Monkey
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
3 Companies That May Be Priced Below Their Estimated Value - Yahoo Finance
Will Phibro Animal Health Corporation (PB8) stock hit analyst forecastsJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Will Phibro Animal Health Corporation stock outperform tech sector in 2025Weekly Trend Summary & Consistent Growth Equity Picks - newser.com
Can Phibro Animal Health Corporation (PB8) stock sustain institutional flowsQuarterly Portfolio Report & Accurate Buy Signal Alerts - newser.com
How hedge fund analytics apply to Phibro Animal Health Corporation stockWatch List & Technical Buy Zone Confirmation - newser.com
Short interest data insights for Phibro Animal Health Corporation2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Q3 EPS Estimate for Phibro Animal Health Boosted by Analyst - Defense World
Why Is Phibro (PAHC) Down 1.1% Since Last Earnings Report? - Yahoo Finance
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Published on: 2025-09-26 06:40:38 - newser.com
Phibro Animal Health Stock Surges 82.1% YTD: What's Fueling It? - Yahoo Finance
Phibro Animal Health Corporation (NASDAQ:PAHC) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Visual analytics tools that track Phibro Animal Health Corporation performancePortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
How to manage a losing position in Phibro Animal Health CorporationBuy Signal & Accurate Entry/Exit Alerts - newser.com
Bendheim Jack, director at Phibro, sells $282k in shares By Investing.com - Investing.com Canada
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 7,022 Shares of Stock - MarketBeat
Bendheim Jack, director at Phibro, sells $282k in shares - Investing.com
Analyzing Phibro Animal Health Corporation with multi timeframe chartsWall Street Watch & Weekly Top Stock Performers List - newser.com
Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock - Yahoo Finance
Phibro Animal Health Corp Azioni (PAHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Phibro Animal Health Corp Azioni (PAHC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK | President and CEO |
Sep 18 '25 |
Sale |
40.26 |
7,022 |
282,732 |
31,338 |
| BENDHEIM JACK | President and CEO |
Sep 09 '25 |
Sale |
40.33 |
14,080 |
567,841 |
45,400 |
| BENDHEIM JACK | President and CEO |
Sep 10 '25 |
Sale |
41.29 |
3,520 |
145,336 |
41,880 |
| BENDHEIM JACK | President and CEO |
Sep 11 '25 |
Sale |
40.95 |
3,520 |
144,137 |
38,360 |
1.54%
1.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):